Amicus Therapeutics (FOLD)

You are trying to access subscriber-only content.

If you are a subscriber, log in here.

If you are not a subscriber, click here for your subscription. Subscribers will have unlimited access to our magazine articles and more!

Article Excerpt

Today, The Cheap Investor Editor Bill Mathews recommends a low-priced, development-stage pharmaceutical company that is appropriate for speculative investors.

Amicus Therapeutics (FOLD)

Amicus Therapeutics, a biopharmaceutical company, focuses on the discovery, development, and commercialization of small molecule drugs known as pharmacological chaperones. … The stock was a high flyer, trading at $7.30…

Comments

You must be logged in to post a comment.